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Behcet’s disease is a rare form of vasculitis that may
have systemic multiorgan involvement. Behcet’s disease was
ﬁrst deﬁned by Hulusi Behcet, a Turkish Professor of
Dermatology, in 1937 as a triad of recurrent aphthous
stomatitis, genital aphthae, and relapsing uveitis. As this
disease can be fatal, an immediate medical treatment is
mandatory. So far there is no speciﬁc pathological testing
or technique available for the diagnosis of the disease,
although the International Study Group criteria for the
disease are of good sensitivity and speciﬁcity. However,
quite a portion of patients are misdiagnosed or have been
delayed diagnosis. During the ensuing 65 years, multiple
systemic associations of the disease including articular,
vascular, gastrointestinal, cardiopulmonary, and neurologic
involvement have become increasingly apparent. Although
the etiology and pathogenesis is not clearly deﬁned, genetic
predisposition, infections, and immunological dysfunctions
have been implicated. Behcet’s disease has been reported
worldwide but has a distinct geographic distribution, with
highest prevalences in countries along with the ancient silk
route. Although much has been learned during recent years
on the pathogenesis and treatment of the disease, it is still an
important cause of morbidity and mortality in areas where it
is prevalent.
The entitled “Musculoskeletal ﬁndings in Behcet’s disease”
addresses the musculoskeletal ﬁndings of Behcet’s disease,
the relationship between Behcet’s disease and spondy-
loarthropathy disease complex, and the status of bone
metabolism in patients with Behcet’s disease.
Professor Fereydoun Davatchi presents us the new diag-
nosis/classiﬁcation criteria for Behcet’s disease. The author
ﬁnds that ICBD criteria have better sensitivity and accuracy
than ISG. In the paper is entitled “Pathophysiology of Behcet’s
disease”, and we think that there is some clinical evidence
suggesting that emotional stress and hormonal alterations
can inﬂuence the course and disease activity of BD. Pro-
fessor Erkan Alpsoy presents that the new evidence-based
treatment is mainly based on the suppression of inﬂamma-
tory attacks of the disease using immunomodulatory and
immunosuppressive agents. In this paper, current state of
knowledge regarding the therapeutic approaches is outlined.
Toprovidearationalframeworkforselectingtheappropriate
therapy along with the various treatment choices, a stepwise,
symptom-based, evidence-based algorithmic approach was
developed. The ﬁfth paper entitled “Genetics of Behc ¸et’s
disease” describes HLA and non-HLA genetic association
studies in BD. In recent years, several genomewide asso-
ciation studies and genetic polymorphism studies have
also found new genetic associations with BD, which may
have a supplementary role in disease susceptibility and/or
severity. The paper entitled “Histopathological evaluation of
Behcet’s disease and identiﬁcation of new diﬀerent skin lesions”
proposes that there has been an increase in the studies
focusing on the histopathological aspects of Behcet’s disease
diagnostic mucocutaneous lesions. Their results emphasize
the value of histopathology and direct immunoﬂuorescence
(DIF) in the diﬀerential diagnosis of Behcet’s disease.
Tuba Kara and Duygu Dusmez Apa discuss the patho-
logic features of BD in the tubuler gut. Professor Aysin2 Pathology Research International
Kokturk describes that the diﬀerential diagnosis depends
on a careful evaluation of the medical history and metic-
ulous physical examination to detect concomitant systemic
manifestations. Sometimes, some laboratory test may help
establish the diagnosis. Subspecialty referral to ophthalmol-
ogy, rheumatology, neurology, and gastroenterology should
be considered when indicated. The paper about BD and
endocrine system shows that the avaliable data suggest that
there is an increased susceptibility to insulin resistance in
patients with BD. And also the authors indicate that not only
anterior hypophysis functions but also posterior hypophysis
functions can be aﬀected. As BD is a disease of autoimmune
process, it may be possible that adrenal insuﬃciency or
alterations in the cortisol levels could be expected.
The article entitled “Potential infectious etiology of
Behcet’s disease” indicates that an infectious agent could
operate through molecular mimicry, and subsequently the
disease could be perpetuated by an abnormal immune
response to an autoantigen in the absence of ongo-
ing infection. Potentia bacteria are Saccharomyces cere-
visiae,m y c o b a c t e r i a ,Borrelia burgdorferi, Helicobacter pylori,
Escherichia coli, Staphylococcus aureus,a n dMycoplasma
fermentans, but the most commonly investigated microor-
ganism is Streptococcus sanguinis. The relationship between
streptococcal infections and Behcet’s disease is suggested
by clinical observations that an unhygienic oral condition
is frequently noted in the oral cavity of Behcet’s disease
patients. Several viral agents, including herpes simplex
virus-1, hepatitis C virus, parvovirus B19, cytomegalovirus,
Epstein-Barr virus, and varicella zoster virus, may also have
some role.
Professor Ozlem Yildirim shows that animal models
allow for a more eﬀective investigations into BD. The paper
entitled “Development of immunopathogenesis strategies to
treat Behc ¸et’s disease” ﬁnds that understanding of the new
pathogenic mechanisms based on molecular structure of
the disease helps us in improving the novel therapeutic
modalities.
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